Top Cannabis Stocks to Watch out for in 2019
Marijuana is the next boom and since legalization, the cannabis business is on a roller coaster ride.
As 420 is approaching, Cannabis stocks are the hot favourite topic for investors these days. Cannabis stock pricing is rising despite the volatility of the stock prices and its legalization in certain countries. Some stock exchanges in the US don’t allow US companies to list because of the legalization status of cannabis at the federal level.
Most companies that are listed on US stock exchanges are Canadian as Canada has legalized marijuana at the federal level. These stocks were launched with maximum Initial Public Offerings (IPO). Some stock failed to capitalize and crashed but some had steady slow growth.
Considering the fact that companies are now diverting their attention in acquisition and diversification of their portfolio, government regulations being relaxed and increase in consumers` demand, has made investors optimistic about cannabis stocks. We have here gathered information of top stocks that deal in cannabis and related accessories that are listed in the US and Other stock exchanges.
The companies listed below are either dealing with cannabis-related products directly or its accessories indirectly.
GW Pharmaceuticals is listed on the NASDAQ Global Market with the ticker symbol of GWPH. GW Pharmaceuticals has operations in both the US and the UK. GW has established itself as a world`s leader in the development of plant-derived cannabinoid therapeutics through its proven drug discovery and development processes, intellectual property portfolio and regulatory and manufacturing expertise.
Tilray is a Canadian pharmaceutical and cannabis company. It is incorporated in the United States with primary operations headquartered in Nanaimo, British Columbia, Canada. Tilray deals in cannabis research, cultivation, processing and distribution. Tilray managed to be the first GMP-certified medical cannabis producer who can supply cannabis flower and extract products to tens of thousands of patients, physicians, governments, pharmacies, hospitals, and researchers on five continents. In July 2018 the company became the first cannabis company to IPO on the NASDAQ and trades under the ticker symbol TLRY.
Cronos Group is a global cannabinoid company, headquartered at Toronto, Ontario, Canada. It has production and distribution across five continents. Cronos Group is inclined in building disruptive intellectual property by advancing cannabis research, technology and product development. Cronos Group’s portfolio branch includes PEACE NATURALS™ which is a global health and wellness platform, and two adult-use brands COVE™ and Spinach™. CRONOS group is listed on NASDAQ with the ticker symbol of CRON.
Canopy Growth Corporations
Canopy Growth Corporation is a cannabis company based in Smiths Falls, Ontario. Formerly known as Tweed Marijuana, it was founded by Bruce Linton and Chuck Rifici in 2013, and later they renamed it to Canopy Growth Corporation in 2015. Canopy was the world's largest cannabis company, based on the value of all shares, or market capitalization as of late September 2018. Canopy Growth Corporation is listed on the New York Stock Exchange with the ticker symbol of CGC.
CannTrust is a federally licensed and regulated producer of medical cannabis-based out of Vaughan, Ontario. CannTrust delivers standardized products that enable physicians to provide accurate dosage to patients. CannTrust is listed on the New York Stock Exchange with a ticker symbol of CTST.
Aphria Inc. is a Canadian cannabis company. It is listed on the Toronto Stock Exchange and the New York Stock Exchange, and has a market capitalization of $3 billion (as of January 2018), making it one of the largest cannabis companies in the world. Aphria is a Licensed Producer of medical cannabis products. Aphria is listed on the New York Stock Exchange with a ticker symbol of APHA.
Aurora Cannabis Inc.
Aurora Cannabis Inc. is a licensed cannabis producer, headquartered in Edmonton, Canada. As of late September 2018, Aurora Cannabis had eight licensed production facilities, five sales licenses, and operations in 18 countries. Aurora is the second largest cannabis company in the world after Canopy Growth Corporation in terms of market capitalization. Aurora Cannabis began trading on the NYSE on October 23rd, 2018 with the ticker symbol of ACB.
Zynerba is developing breakthrough therapies to transform the quality of lives of patients and their families as they battle these conditions. It aims at advancing the science of therapeutic cannabinoids. This will help patients who are struggling with severe neuropsychiatric conditions which include Fragile X syndrome (FXS), Autism Spectrum Disorder (ASD), 22q, and a heterogeneous group of rare and ultra-rare epilepsies known as developmental and epileptic encephalopathies (DEE). Zynerba is listed on the NASDAQ stock exchange with the ticker symbol of ZYNE.
Corbus Pharmaceuticals Holdings Inc.
Corbus Pharmaceuticals Holdings, Inc. is a Phase 3 clinical-stage pharmaceutical company. It focuses on the development and commercialization of novel therapeutics. This in turn, will treat inflammatory and fibrotic diseases by leveraging its industry-leading pipeline of endocannabinoid system-targeting drug candidates. Corbus Pharmaceuticals is listed on NASDAQ with the ticker symbol of CRBP.
CV Sciences Inc.
CV Sciences, Inc. operates two distinct business segments
- First is the Drug Development Division, which focuses on developing and commercializing novel therapeutics utilizing synthetic CBD.
- Second is the Consumer Product Division, which is into manufacturing, marketing and selling of plant-based CBD products to a range of market sectors.
CV Sciences, Inc. has primary offices and facilities in San Diego, California and Las Vegas, Nevada. CV Sciences Inc. is listed on OTC Market with a ticker symbol of CVSI.
About Cannabis Drinks Expo
Cannabis Drinks Expo is a must-attend event for those curiously eying the future of the burgeoning U.S. cannabis industry.
We also cover the key issues surrounding the likelihood and timescale for legalization to other countries, as well as the impact of legalized cannabis on the traditional alcoholic and non-alcoholic drinks markets globally.
Who should Visit?
Cannabis Drinks Expo promises to be relevant for anyone involved in the development, production, distribution and retailing of cannabis and related products. It will also provide a vital networking opportunity for political analysts, medical experts and those involved in the development and implementation of legalized cannabis into new markets.
Attend Cannabis Drinks Expo in preferred city
Who should exhibit?
If you’re serious about the cannabis drinks category, we’re still keeping it as real as ever. At Cannabis Drinks Expo, our goal is to empower you with knowledge, network, and platform so you can grow and build your cannabis drinks business. CDE is where you will find cannabis brands and suppliers who are serious about building their business in this category exhibit.
Exhibit in preferred city
Potential exhibitors include (but not limited to): Medical marijuana producers, Cannabis growers, Cannabis producers/ product developers, Cannabis processors, Cannabis distributors/transporters, Wineries, Breweries, Distilleries, Branded drinks companies, Drinks manufacturers/producers, Pharma companies, Equipments and service providers, CBD manufacturers, Marijuana-Infused products and edibles providers, Testing and laboratory services, Logistics and supply chain operators, Drinks distributors/wholesalers, Drinks importers, Lobbyists/ public affairs businesses, Political advisors, and more.